Literature DB >> 18045961

Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer.

Paolo Miccoli1, Michele N Minuto, Clara Ugolini, Eleonora Molinaro, Fulvio Basolo, Piero Berti, Aldo Pinchera, Rossella Elisei.   

Abstract

Total thyroidectomy and central neck dissection are the procedures of choice in patients affected with medullary thyroid cancer. It is known that a medullary thyroid cancer with node metastases can be rarely cured, and therefore the utility of a modified radical neck dissection in the absence of suspicious node metastases still needs further evidence. The study aims to verify whether other epidemiological and pathological parameters could affect the prognosis of medullary thyroid cancer patients. We prospectively studied 70 medullary thyroid cancer patients consecutively operated on (from 2000 to 2004) at the same institution and analysed by the same pathologists. All patients underwent total thyroidectomy and central lymphadenectomy. In 27 cases, the ipsilateral (n=19) or bilateral (n=8) modified radical neck dissection was performed in the presence of suspicious lateral neck node metastases. After surgical treatment, basal and stimulated serum calcitonins (Cts) were measured in all patients. Follow-up ranged between 1 and 4 years. Patients were considered 'cured' when stimulated Ct was undetectable. Age, sex, tumour size, tumour capsule, multicentricity, nodes in the central neck and mean number of positive nodes were analysed in 'cured' and 'not-cured' patients. The presence of node metastases in the central compartment was significantly correlated with the outcome of the patients, being present in 9 and 72% of cured and not-cured patients respectively (P<0.000001). Tumour size was also significantly correlated with the outcome of the disease (P<0.00006). The presence of the tumour capsule correlated with better prognosis (P=0.0005) and absence of node metastases (P=0.0080). By multivariate analysis, the presence of node metastasis remained the most significant variable affecting the outcome of the disease (P=0.000014). Our results show that the outcome of encapsulated cancer is significantly better regardless of tumour size and node metastases. Although the early diagnosis and the extensive surgical treatment may favour the good outcome of medullary thyroid cancer, they do not always guarantee the definitive cure of the disease, being the capsular infiltration an independent bad prognostic factor.

Entities:  

Mesh:

Year:  2007        PMID: 18045961     DOI: 10.1677/ERC-07-0128

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  18 in total

1.  Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study.

Authors:  M Puccini; G Manca; C Ugolini; V Candalise; A Passaretti; J Bernardini; G Boni; P Buccianti
Journal:  J Endocrinol Invest       Date:  2014-06-21       Impact factor: 4.256

2.  Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications.

Authors:  Michele N Minuto; Piero Berti; Mario Miccoli; Clara Ugolini; Valeria Matteucci; Manuela Moretti; Fulvio Basolo; Paolo Miccoli
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

3.  Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).

Authors:  Françoise Kraeber-Bodéré; Pierre-Yves Salaun; Catherine Ansquer; Delphine Drui; Eric Mirallié; Alain Faivre-Chauvet; Jacques Barbet; David M Goldenberg; Jean-François Chatal
Journal:  Tumour Biol       Date:  2012-03-07

4.  Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?

Authors:  Per Bümming; Håkan Ahlman; Bengt Nilsson; Ola Nilsson; Bo Wängberg; Svante Jansson
Journal:  Langenbecks Arch Surg       Date:  2008-07-15       Impact factor: 3.445

5.  Prognostic values of thyroid tumours.

Authors:  Suzana Manxhuka-Kerliu; Emine Devolli-Disha; Arsim Gerxhaliu; Halil Ahmetaj; Arijeta Baruti; Sadushe Loxha; Hajdin Thaqi
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

6.  Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.

Authors:  Sébastien Aubert; Amandine Berdelou; Viviane Gnemmi; Hélène Behal; Robert Caiazzo; Michèle D'herbomez; Pascal Pigny; Jean Louis Wemeau; Bruno Carnaille; Florence Renaud; Brigitte Bouchindhomme; Emmanuelle Leteurtre; Michael Perrais; François Pattou; Christine Do Cao
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

7.  Minimally invasive surgical techniques in the management of differentiated thyroid cancer.

Authors:  N Tucker; J Mitchem; W Gillanders
Journal:  Otorinolaringologia       Date:  2013-06

8.  Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity?

Authors:  Simona Censi; Elisabetta Cavedon; Sara Watutantrige-Fernando; Susi Barollo; Loris Bertazza; Jacopo Manso; Maurizio Iacobone; Davide Nacamulli; Francesca Galuppini; Gianmaria Pennelli; Caterina Mian
Journal:  Eur Thyroid J       Date:  2018-12-06

9.  Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.

Authors:  M M Moura; R A Cabrera; S Esteves; B M Cavaco; P Soares; V Leite
Journal:  J Endocrinol Invest       Date:  2021-02-11       Impact factor: 4.256

10.  Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer.

Authors:  F Kraeber-Bodéré; D M Goldenberg; J F Chatal; J Barbet
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.